I. Introduction
Hyperlipidaemiais the greatest risk factor contributing to atherosclerosis [1] [2] [3] [4] [5] and occurrence of coronary heart disease and cerebrovascular accidents. Hence hypolipidemic [6] molecules are extensively usedas prophylactic agents to prevent such atherosclerosis induced disorders. But these hypolipidemic drugs [7] are not free from adverse effects. Pancreatitis due to moiety of statin is a well-known adverse effect and HMG-CoA reductase inhibitors have also been reported to cause hyperglycemia and FDA has given a warning to this effect. Many plant derivatives and domestic remedies have been screened for their hypolipidemic action. More than 70 medicinal plants have been documented to have significant hypolipidemic action. Beginning of last century evidence of lipid lowering [8] properties of medicinal plants has accumulated [9] [10] [11] . Ethno botanical information [12] indicates that more than 800 plants are used as traditional and remedies for the treatment of diabetes and lowering the lipid profile.Taking these finding forward is mandatory to develop new drugs in this area. Hence further research into identifying the active principle, conducting preclinical studies and if possible clinical studies is needed to evaluate the Antihyperlipidemic [13] [14] [15] [16] activities of this plant.
II. Materials And Methods

Plant
Pharmacological studies have acknowledged the value of medicinal plants as potential source of bioactive compounds. Plants are known to be the source of many chemical compounds. Aeglemarmelos [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] , commonly known as Bael, is a spiny tree belonging to the family Rutaceae Sub family:AurantioideaeGenus:Aegle.The leaves, roots, bark, seeds and fruits are edible and have medicinal values. The plant was authenticated by taxonomist and specimen (No.24/Am) is preserved in the department of Research Pharmacology, Bapuji Pharmacy College, Davangere (India). 30 The leaves of Aeglemarmelosas raw material were collected from a home garden. The leaves collected were washed with tap water to remove the dust and dirt. They were dried under sun drying for 3 hours. The dried leaves were powdered using a mixer to obtain powder of the raw leaves of Aeglemarmelos. Carbon dioxide (purity 99.99%) as solvent contained in a dip tube cylinder is installed. Supercritical CO 2 was obtained by using SFT-10 Supercritical Fluid Pump. The SFT-10 is a high precision carbon dioxide pump designed to deliver liquid carbon dioxide at pressures up to 10,000 psi (68.9 MPa).
Supercritical extraction
Experimental procedure
1. Turn on the power to the SFT-110 SFE unit. 2. Turn on the Peltier cooler at least thirty minutes prior to the start of the experiment. 3. Powder 50 grams of raw material i.e., dried Aeglemarmelos leaves. 4. Place the powdered Aeglemarmelos leaves into the SFT-110 Unit's processing vessel and seal. 5. Ensure that both the static/dynamic valve and restrictor valve are closed. 6. Open the carbon dioxide tank valve to allow the carbon dioxide to come into the unit (~750 psi). 7. Set the oven temperature to 40C and the restrictor block to 40C. 8. Set the pressure on the pump to 2000 psi. The pump should begin to actuate to pressurize the sample vessel.
This will take between 12-15 minutes. 9. Once the pressure is up to 2000 psi, allow the sample to "soak" at that pressure for 15 minutes for 40C. 10. Open the static/dynamic valve to allow free flow of carbon dioxide through the restrictor valve. Adjust the restrictor valve to achieve about 24ml/min of liquid carbon dioxide. Flow dynamically for 15 minutes. The pump should actuate and continue to maintain sample vessel pressure. 11. Close the static/dynamic valve and allow to "soaking" for an additional 15 minutes before repeating the dynamic flow step above. Repeat the static soak and dynamic flow step 5 more times. 12. Set the vessel temperature to ambient and set the pressure control down to ambient. Allow the unit to vent.
When the vessel has reached ambient pressure, disconnect the inlet and outlet fittings, open the vessel and remove the Aeglemarmelos powder. 13. Similar procedure is carried out by varying the parameters such as temperature (45C, 50C and 55C), pressure (2000 psi, 3000 psi and 4000 psi) and time (20, 25 and 40 minutes). 14. Phytochemical investigations of all extracts were carried out in order to detect the presence of the following class of compounds.
Column chromatography
The obtainedAeglemarmelos powder (10 gm) was subjected to column chromatographic methods. Thesupercritical fluid extract (10 g) was chromatographed over silica gel (100-200 mesh) on column 55 cm length and 6 cm diameter. Elution was carried out with solvent mixtures of increasing polarities. Fractions were collected in 100 ml portions and monitored by TLC (silica Gel adsorbent) and the fractions showing similar spots are pooled together. Elution with ethyl acetate: ethanol (EA: ET-OH (40: 60) gave brown crystalline solid (450 mg) and named as AmF1. Similarly, elution with EA: ET-OH (30:70) yielded shiny brown coloured crystalline solid (1.5g) and was named as AmF2.
Acute toxicology test 31
Acute toxicity study was performed using albino mice and doses were fixed as per OECD guideline No.423 and adopted CPCSEA protocol. Wister rats were made hyperilipidemic by injecting Triton-induced with a dose of 400 mg ⁄kg (i.p), body weight is chilled citrate buffer (pH 4.5),
Anti-hyperilipidemic activity
Anti-hyperilipidemic activity of fractions AmF1 and AmF2 was performed on Triton-induced hyperlipidemic rats and was evaluated as per the method described by Moss11, Vogel12 and Hirch. Animals were divided in to six groups. After 18 hours blood samples were collected from retro orbital sinus puncture under mild anaesthesia and transferred directly into centrifuge tube and allowed to clot at room temperature for 20-25 min and centrifuged at 2000 rpm. The supernatant clear serum thus obtained was transferred carefully with the help of micropipette into small test tubes for estimation. The serum concentration of total cholesterol, triglycerides, HDL-cholesterol and LDL-cholesterol were measured by standard procedure using auto analyser (RA 50 model, Miles India Limited).
Statistical Analysis:
Data were statically analyzed as meant ±SEM and expressed as significant P<0.001 using one way ANOVA 
III. Results And Discussion
The present investigation was focused on to evaluate antihyper-lipidemic activities of Aeglemarmelos leaves extract and its fraction AmF1.The result of the present study demonstrates the efficiency of Supercritical extract Am and fraction AmF1. The plant secondary metabolite like flavonoids are responsible to monitoring the normal lipid profile is Triton induced diabetic rats due to LA of lecithin acetyl transferase (LCAT), which regulates blood lipids and glucose concentration. The LCAT plays a key role in the incorporation of free cholesterol into HDL (this may increase HDL) and transferring it back to VLDL and LDL which are taken back later in liver cells.
Several investigation reports have positive witnessed that, increase in HDL-C is associated with decrease in coronary artery diseases. The result of the present study suggested that extract and fraction of (AmF1) illustrate significant -antihypolipidemic activity (P<0.001HS) and results were tabulated in Table - 
Tables
V. Conclusion
The present investigation was focused on to evaluateantihyper-lipidemic activities of leaves extract 
